Biomedical evidence is essential.

Embase is a crucial resource for discovering biomedical evidence within published, peer-reviewed literature, in-press publications and conference abstracts.




See how comprehensive and up-to-date biomedical information supports your research.

  • One user
  • Access to Embase.com
  • Search > 30 million abstracts and indexes
  • Search > 1.9 million conference abstracts
  • Search using Emtree: > 71,000 preferred terms and 300,000 synonyms
  • 0 email alerts
  • Unlimited saved searches




Prepare a single systematic review or assess a product’s safety and uniqueness.

  • One user
  • Access to Embase.com
  • Search > 30 million abstracts and indexes
  • Search > 1.9 million conference abstracts
  • Search using Emtree: > 71,000 preferred terms and 300,000 synonyms
  • 5 email alerts
  • Unlimited saved searches

Annual Subscription



Ensure effective pharmacovigilance and high-quality systematic reviews.

Contact Sales

  • Mutiple user, IP-based access
  • Access to Embase.com
  • Search > 30 million abstracts and indexes
  • Search > 1.9 million conference abstracts
  • Search using Emtree: > 71,000 preferred terms and 300,000 synonyms
  • Unlimited email alerts
  • Unlimited saved searches


Contact Sales

Biomedical Evidence is Essential

To successfully perform critical functions such as compliant adverse event reporting, systematic reviews for evidence-based medical decisions and drug and medical device efficacy studies, pharmaceutical and life sciences organizations require a wide array of current and historical biomedical evidence and information. The challenge lies in performing comprehensive searches efficiently so that research teams stay up to date.

Celebrating Over 40 Years of Exceptional Embase Quality

Did you ever wonder how an article is added to Embase? Follow the path of an article into Embase and learn how our full-text indexing, strict quality controls, Emtree thesaurus and Embase search features support you in your research.

Relevant and Accessible
Biomedical Data and Literature

Embase is a valuable resource for discovering biomedical evidence within published, peer-reviewed literature, in-press publications and conference abstracts. A search in Embase delivers the most relevant abstracts from the biomedical literature based on deep, full-text indexing of drug, disease and medical device information.

Compliance with Drug
Safety Regulations

Drug safety legislation is complex and ever changing, requiring strict compliance, and only efficient pharmacovigilance workflows can meet the stringent requirements of regulatory agencies.

Information for Every Step
of Medical Device Design

Medical device manufacturers need relevant information to prove that their product is needed, effective, safe and reimbursable.

Evidence-based Medicine
for Systematic Reviews

Evidence-based medicine solutions have the potential to save lives. Finding all the relevant information from the biomedical literature is vital to creating high-quality systematic reviews.

Embase User Benefits


international journal source titles


records covering 27 years of biomedical research


available as one file


of records have abstracts available


Can I purchase access for just my personal use? +

All three plans give you full access to all of the biomedical literature in Embase, allowing you to search over 30 million records from a total of more than 8,500 journals. This includes all MEDLINE content, along with over 2800 journals and 1.4 million conference abstracts not in MEDLINE.

Note that with the 7-day plan, which is for individual use, the email alert function is not active. With the 30-day plan, which is also for individual use, you can create up to 5 automated email alerts, which will support you in performing systematic reviews over the course of a month.

With a full, annual subscription, which is IP-based access for multiple users, you get access to all of the features and content of Embase. This includes an unlimited number of automated email alerts and the full range of data export possibilities.

What happens when I place an order? +

You will receive two emails. One is an order confirmation with your purchase information. The other will have your registration ID and password and the instructions for registering your Embase account.

Are my options for searching in Embase the same, regardless of which package I choose? +

Yes. Your access to search forms and database browsing options is the same for all the plans.

If you are searching for a particular term, Embase allows you to create simple searches using 'Quick Search'. If you want to perform a more complex search with more filters and limits, you have the option to use the 'Advanced', 'Drug', 'Disease', 'Device' and 'Article' searches.

You can also browse the database using the Embase thesaurus 'Emtree' or the Embase journal or author lists. Browsing is a very useful way of discovering information that you might not have realized you could access.

Do Embase search results link to the full-text articles? +

Search results include title, abstract, author and additional information, as well as drug, disease and medical device index terms identified from the full-text of articles. A link is provided to the full-text article — the ability to access full-text articles depends on whether the article is open access and therefore freely available or if you have a subscription to the journal in which the article is published. In cases where you do not have a subscription to the journal, the full-text link will redirect you to the publisher’s page where you may purchase the article.

Copyright © 2015 Elsevier B.V.
Cookies are used by this site. To decline or learn more, visit our Cookies page.


Can I purchase access for just my personal use?

Yes. Both the 7-day and 30-day plans are designed for individuals rather than organizations. The 7-day license is for 7 consecutive days. After you purchase the plan, your account will be active for 168 hours from the first time you log into Embase. Similarly, the 30-day plan is for 30 consecutive days and your account will be active from the first time you log in into Embase. If a large team or organization needs access to Embase, you should consider the full subscription.

Can I share my user name and password with my colleagues?

No. Each account is for use by one person only. You should not share your log in credentials with anyone else.

Can I create multiple user profiles using my registration ID?

No. Each registration ID for the 7-day and 30-day plans only permits the creation of one user profile. Separate plans should be purchased for each user.

I’ve forgotten my password to the Elsevier Store. What can I do?

Please select the 'Forgot your password?' link on the 'Login' page. You will be prompted to enter the email address that you registered with the Elsevier Store. You’ll then receive an email with a link that lets you log in and create a new password. When you’ve created it, you’ll be asked to re-enter it to confirm it.

I forgot my user name or password to Embase. What can I do?

Please select the 'Forgot your password?' link on the 'Login' page. You will be prompted to enter the email address that used when you registered with Embase. You’ll then receive an email with a link that lets you log in and create a new password. When you’ve created it, you’ll be asked to re-enter it to confirm it.

Are there guides or videos for using Embase?

Yes. There is a comprehensive set of guides and videos in Embase Help. We’ll also send you links to helpful guides, webinars and instructional videos via email.

What do I do if my payment cannot be processed?

In the unlikely event that your payment cannot be processed, please do not resubmit the order. Contact the Help Desk at cs@elsevier.com and provide the Unique Order Number along with a valid credit card number and correct billing information.

Can I renew my plan when it expires?

Yes. When you renew or upgrade your plan, you do not need to register to Embase again or create a new user profile. The user name and password that you create for Embase does not expire. After renewal, you can log in normally with these credentials using the “Login using your Elsevier credentials” field.

I have purchased Embase but have not received an email from Elsevier. What should I do?

If you have contacted Elsevier or placed an order and not yet received a response, please check your ‘Junk’ or ‘Spam' folder. It is possible that Elsevier is not on your ‘safe sender’ list and any response sent by Elsevier is automatically directed to this folder by your email system. If the email has indeed been delivered here, you can add the relevant Elsevier email address (es) to your address book and/or add Elsevier to your 'safe-senders' list, so that all future correspondence from us will be directed straight to your inbox.

If the email from Elsevier is not in your ‘Junk’ or ‘Spam’ folder or have any further questions, please Contact Us

How do I get a refund?

If the registration ID has been redeemed and Embase has been accessed, then it is not possible to refund the order.

Prior to confirmation of purchase, customers are asked to check their order carefully. Elsevier cannot consider mistakes in the order as grounds for a refund.

What happens when my plan ends?

After your final session of your 7-day or 30-day plan ends, you cannot log in again. If you attempt to log in, you will be redirected to the Embase page on the Elsevier website.

Why does Embase need my registration form data?

Embase uses your registration data to store your Saved Searches, send you email alerts, add records to the Clipboard and perform other administrative tasks.

How is Embase indexed?

Fully indexed records in Embase are manually indexed using the full text of each article: index terms identified by trained indexers with a biomedical background are controlled against Emtree before being added to Embase records. Indexed records are available online within two weeks (on average) from receipt of the journal issue.

For journal titles covered in Embase.com but indexed by MEDLINE, index terms assigned by the NLM from the MeSH thesaurus are mapped to Emtree.

Articles in Press, In-Process records and Conference abstracts are automatically indexed. Once the Article in Press and In-Process records become published, they are manually indexed as described above.

What journals are included in Embase?

You can download a complete list of the journals in Embase here.

You can also see a list of the journals in Embase within the interface. Go to the ‘Browse’ dropdown menu and choose ‘Journals’. This gives you a complete alphabetical list of the journals (excluding the journal titles covered in Embase.com but indexed exclusively by MEDLINE). You can use the alphabetical navigation at the top of the list to move between letters.

What conferences are included in Embase?

You can download a complete list of the conferences covered in Embase here.

How does Embase cover MEDLINE content?

Over 2800 journals are unique to Embase and 3000 journal titles are covered by both Embase and MEDLINE. Both of these journal types are indexed by Embase using Emtree. 2500 journal from MEDLINE, which is produced by the U.S. National Library of Medicine (NLM) and forms the core of PubMed, are not indexed by Embase using Emtree, but are instead indexed using the MEDLINE thesaurus MeSH.

Indexed MEDLINE records are delivered to Elsevier on a daily basis, and are incorporated into Embase after de-duplication with records already indexed by Elsevier to produce so-called MEDLINE-unique records. These MEDLINE-unique records are not re-indexed by Elsevier. However, their indexing is mapped to Emtree terms used in Embase to ensure that Emtree terminology can be used to search all Embase records, including those originally derived from MEDLINE.

Store.Elsevier.com Agreement for Elsevier Embase.com

This agreement (“Agreement”) is made by and between Elsevier B.V., Radarweg 29, 1043 NX Amsterdam, The Netherlands (“Elsevier”) and the individual (the “Subscriber”) identified in the order form (“Order Form”) on the website at http://store.elsevier.com (“Website”) as of the date that the Subscriber submits the Order Form by selecting the “Place Order” button thereon. This Agreement expressly incorporates by reference and includes the Website’s Terms and Conditions, Privacy Policy, and any guidelines, rules or disclaimers that may be posted and updated on specific web pages of the Website or on notices that are sent to the Subscriber. The Subscriber acknowledges and agrees that a maximum of four (4) Orders may be placed via the website per subscriber per annum.

Section 1. Subscription.

1.1 Subscribed Products.

Elsevier hereby grants to the Subscriber the non-exclusive, non-transferable right to access and use the Embase database, (the “Subscribed Products”) and provide the Subscribed Products to its Authorized Users (as defined herein) subject to the terms and conditions of this Agreement.

1.2 Authorized Users.

Authorized Users are the individuals permitted by the Subscriber to access the Subscribed Products.

1.3 Authorized Uses.

Each Authorized User may access, search, browse and view the Subscribed Products and make electronic copies of and store for the exclusive and personal use of such Authorized User individual items from the Subscribed Products. The Subscribed Products are licensed, not sold, to the Subscriber. Elsevier permits that the Subscriber may print download and store a reasonable portion of individual items from the Subscribed Products.

1.4 Restrictions on Use of Subscribed Products.

Except as may be expressly permitted in this Agreement, the Subscriber and its Authorized Users may not:
- abridge, modify, translate or create any derivative work based on the Subscribed Products;
- remove, obscure or modify in any way any copyright notices, other notices or disclaimers as they appear in the Subscribed Products;
- reproduce, retain, distribute, sell, rent, lease or lend the Subscribed Products;
- bypass, modify, defeat or circumvent security measures that protect the Subscribed Products; or
- use any robots, spiders, crawlers or other automated downloading programs, algorithms or devices to continuously and automatically search, scrape, extract, deep link, index or disrupt the working of the Subscribed Products.

1.5 Intellectual Property Ownership.

The Subscriber acknowledges that all right, title and interest in and to the Subscribed Products remain with Elsevier and its suppliers, except as expressly set forth in this Agreement, and that the distribution of the Subscribed Products could materially harm Elsevier and its suppliers.

Section 2. Elsevier performance obligations.

2.1 Access to Subscribed Products.

Elsevier will make the Subscribed Products accessible to the Subscriber and its Authorized Users from the website www.embase.com.

2.2 Quality of Service.

Elsevier shall use reasonable efforts to provide the Subscribed Products with a quality of service consistent with industry standards, specifically, to provide continuous service with an average of 98% up-time per year, with the 2% down-time including scheduled maintenance and repairs performed at a time to minimize inconvenience to the Subscriber and its Authorized Users, and to restore service as soon as possible in the event of an interruption or suspension of service.

2.3 Withdrawal of Content.

Elsevier reserves the right to withdraw from the Subscribed Products content that it no longer retains the right to provide or that it has reasonable grounds to believe is unlawful, harmful, false or infringing.

Section 3. Subscriber performance obligations

3.1 Authorized Access.

Access to the Subscribed Products shall be authenticated for no more than five (5) Authorized Users by the use of no more than five (5) ScienceDirect registration usernames and passwords provided by Elsevier to the Subscriber.

3.2 Protection from Unauthorized Access and Use.

The Subscriber shall use reasonable efforts to:
- ensure that access to and use of the Subscribed Products is limited to the personal use of the Authorized Users only and that all Authorized Users are notified of and comply with the usage restrictions set forth in this Agreement;
- ensure that any passwords or credentials used to access the Subscribed Products are issued only to Authorized Users and that neither the Subscriber nor its Authorized Users divulge any passwords or credentials to any third party; and
- immediately upon becoming aware of any unauthorized use of the Subscribed Products, inform Elsevier and take appropriate steps to ensure that such activity ceases and to prevent any recurrence. In the event of any unauthorized use of the Subscribed Products, Elsevier may suspend the access. The Subscriber shall not be liable for unauthorized use of the Subscribed Products by any Authorized Users provided that the Subscriber did not intentionally assist in or encourage such unauthorized use or permit such unauthorized use to continue after having actual notice thereof.

3.3 System Requirements

Use of the Subscribed Products requires compatible devices, internet access, and certain software (fees may apply); may require periodic updates, and may be affected by the performance of these factors. Subscriber agrees that meeting these requirements, which may change from time to time, is the responsibility of the Subscriber.

Section 4. Fees and payment terms.

The Subscriber shall pay to Elsevier the fees (the “Fees”), including any applicable taxes, for access to and use of the Subscribed Product identified by the Subscriber in the Shopping Cart on the Order Form at the rates in effect when the charges were incurred.

Section 5. Term.

The term of this Agreement shall commence when the access code is entered for the first time and shall continue for one (1) year, in accordance with the usage provisions of this Agreement.

Section 6. Elsevier warranties and indemnities

6.1 Warranties

Elsevier warrants to the Subscriber that Elsevier has the necessary rights to grant this subscription, and that use of the Subscribed Product by the Subscriber in accordance with the terms of this Agreement will not infringe the intellectual property rights of any third party.

6.2 Indemnities.

Elsevier will indemnify, defend and hold harmless the Subscriber from and against any loss, damage, costs, liability and expenses (including reasonable attorneys’ fees) arising from or out of any third-party action or claim that use of the Subscribed Product in accordance with the terms and conditions herein infringes the intellectual property rights of such third party. If any such action or claim is made, the Subscriber will promptly notify and reasonably cooperate with Elsevier. This indemnity obligation will survive the termination of this Agreement.

6.3 Limitations of Indemnification.

Elsevier will have no obligation under Section 6.2 to the extent that: (a) any alleged infringement relates to use of the Subscribed Product in combination with other data products, processes or materials not provided by Elsevier or any modification of the Subscribed Product not made or authorized by Elsevier; (b) the Subscriber continues allegedly infringing activity after being notified thereof or after being informed of available modifications that would have avoided the infringement; (c) the Subscriber’s use of the Subscribed Product is not strictly in accordance with the terms of this Agreement; or (d) any alleged infringement is related to the Subscriber’s failure to implement, without the prior written consent of Elsevier, any available improvements or corrections to the Subscribed Product provided by Elsevier that could have remedied such claim.

6.4 Remedies for Third Party Injunction.

If the Subscriber is enjoined from using the Subscribed Product due to an infringement of a third party’s intellectual property right, or Elsevier believes an injunction may occur, Elsevier will have the option to either (a) modify the Subscribed Product to render it non-infringing while maintaining substantial equivalence, or (b) procure a license or subscription which permits the Subscriber at no additional cost to continue to use the Subscribed Product, or (c) terminate this agreement for the Subscribed Product and refund to the Subscriber a portion of the fees paid for the Subscribed Product, prorated to the end of the then-current term.

6.5 Disclaimer.


6.6 Limitation of Liability.

Except for the express warranties and indemnities stated herein and to the extent permitted by applicable law, in no event will Elsevier or its suppliers be liable for any indirect, incidental, special, consequential or punitive damages including, but not limited to, loss of data, business interruption, loss of profits, results of use, inaccuracy of data, cost of procurement of substitute goods, services or technology, arising out of or in connection with this Agreement, nor will the liability of Elsevier and its suppliers to the Subscriber exceed a sum equal to the Fees paid by the Subscriber hereunder, even if Elsevier or any supplier has been advised of the possibility of such liability or damages.

Section 7. Risk of loss

Risk of loss for the Subscribed Product transfers when the Subscriber downloads or accesses the Subscribed Product.

Section 8. General.

8.1 Force Majeure.

Neither party’s delay or failure to perform any provision of this Agreement as a result of circumstances beyond its control (including, but not limited to, war, strikes, fires, floods, governmental restrictions, power failures, telecommunications or Internet failures or damage to or destruction of any network facilities or servers) shall be deemed a breach of this Agreement.

8.2 Severability.

The invalidity or unenforceability of any provision of this Agreement shall not affect any other provisions of this Agreement.

8.3 Entire Agreement.

This Agreement contains the entire understanding and agreement of the parties and merges and supersedes any and all prior and contemporaneous agreements, communications, proposals and purchase orders, written or oral, between the parties with respect to the subject matter contained herein.

8.4 Governing Law.

This Agreement will be governed by and construed in accordance with the laws of The Netherlands, without regard to conflict of law principles, and the parties irrevocably consent to the exclusive jurisdiction of the courts located in Amsterdam, The Netherlands, with respect to any action or suit arising out of or pertaining to this Agreement (except where local law requires).

8.5 Assignment.

The Subscriber shall not assign, transfer or license any of its rights or obligations under this Agreement unless it obtains the prior written consent of Elsevier, which consent shall not unreasonably be withheld.

8.6 Privacy.

Elsevier shall not, without the prior written consent of the Subscriber, transfer any personal information of any Authorized Users to any non-affiliated third party or use it for any purpose other than as described in this Agreement and in the online privacy policy for the relevant online service.

8.7 Notices.

All notices to Elsevier shall be sent to Elsevier B.V., Radarweg 29, 1043 NX Amsterdam, The Netherlands, Elsevierstore@elsevier.com, and all notices to the Subscriber shall be delivered to the contact details identified on the Order Confirmation or to such other address(es) as the party concerned designates by notice hereunder.